CorMedix Inc.
CRMD Real Time Price USDRecent trades of CRMD by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by CRMD's directors and management
Government lobbying spending instances
-
$150,000 Oct 21, 2024 Issue: Health Issues
-
$240,000 Jul 22, 2024 Issue: Health Issues
-
$330,000 Apr 22, 2024 Issue: Health Issues
-
$360,000 Jan 22, 2024 Issue: Health Issues
-
$230,000 Oct 20, 2023 Issue: Health Issues
-
$50,000 Jul 20, 2023 Issue: Health Issues
-
$30,000 Jul 14, 2023 Issue: Medicare/Medicaid
-
$10,000 Oct 17, 2018 Issue: Health Issues
-
$20,000 Apr 19, 2018 Issue: Health Issues
-
$30,000 Jan 19, 2018 Issue: Health Issues
-
$30,000 Oct 17, 2017 Issue: Health Issues
-
$30,000 Jul 19, 2017 Issue: Health Issues
-
$30,000 Apr 20, 2017 Issue: Health Issues
-
$30,000 Jan 23, 2017 Issue: Health Issues
-
$30,000 Oct 20, 2016 Issue: Health Issues
-
$30,000 Jul 20, 2016 Issue: Health Issues
-
$30,000 Apr 20, 2016 Issue: Health Issues
-
$30,000 Jan 20, 2016 Issue: Health Issues
-
$30,000 Oct 20, 2015 Issue: Health Issues
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of CRMD in WallStreetBets Daily Discussion
Recent insights relating to CRMD
Recent picks made for CRMD stock on CNBC
ETFs with the largest estimated holdings in CRMD
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CRMD Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.